---
title: Kestra Medical Technologies - AHA 2025
image: https://resources.kestramedical.com/hubfs/2025%20AHA/ASSURE-Composition-3.png
---

[Skip to content](https://resources.kestramedical.com/aha-2025#main-content)

[![Kestra\_Color\_RGB-602x164-8ac7dfd](https://resources.kestramedical.com/hs-fs/hubfs/Kestra_Color_RGB-602x164-8ac7dfd.png?width=200&height=55&name=Kestra_Color_RGB-602x164-8ac7dfd.png "Kestra_Color_RGB-602x164-8ac7dfd")](https://resources.kestramedical.com/?hsLang=en)

[For Patients](https://www.kestramedical.com/patients)

[For Providers](https://www.kestramedical.com/providers)

[Support](https://www.kestramedical.com/contact)

|

[Kestra CareStation](https://carestation.kestramedical.com/Login)

# Your Partner in SCA Risk Management

## Join Us at AHA 2025

Booth 4617 | November 7-10 | New Orleans, LA

[View Event Highlights](https://resources.kestramedical.com/aha-2025#Booth-Highlights)

![ASSURE-Composition-3](https://resources.kestramedical.com/hs-fs/hubfs/2025%20AHA/ASSURE-Composition-3.png?width=1757&height=2000&name=ASSURE-Composition-3.png "ASSURE-Composition-3")

- [SCD Risk](https://resources.kestramedical.com/aha-2025#SCD-Risk)
- [Late-Breaking Abstact](https://resources.kestramedical.com/aha-2025#Abstract)
- [CRS Platform](https://resources.kestramedical.com/aha-2025#Devices)
- [Booth Highlights](https://resources.kestramedical.com/aha-2025#Booth-Highlights)
- [Contact](https://resources.kestramedical.com/aha-2025#Contact)

- Discover More 
    - [SCD Risk](https://resources.kestramedical.com/aha-2025#SCD-Risk)
    - [Late-Breaking Abstact](https://resources.kestramedical.com/aha-2025#Abstract)
    - [CRS Platform](https://resources.kestramedical.com/aha-2025#Devices)
    - [Booth Highlights](https://resources.kestramedical.com/aha-2025#Booth-Highlights)
    - [Contact](https://resources.kestramedical.com/aha-2025#Contact)

 

## GDMT Takes Time. SCD Doesn’t Wait.

The first 90 days after diagnosis carry the highest risk of sudden cardiac death (SCD) in patients with reduced EF (≤35%)—leaving a critical gap in protection as GDMT is titrated to full effect.1

![MARC-030A Landing Page, Conference AHA25, factoid card](https://resources.kestramedical.com/hs-fs/hubfs/2025%20HFSA/MARC-030A%20Landing%20Page%2c%20Conference%20AHA25%2c%20factoid%20card.png?width=903&height=716&name=MARC-030A%20Landing%20Page%2c%20Conference%20AHA25%2c%20factoid%20card.png "MARC-030A Landing Page, Conference AHA25, factoid card")

![IMG-026C-Graphic,-SCD-PROTECT-Time-to-Appropriate-Treatment,-Graph](https://resources.kestramedical.com/hs-fs/hubfs/IMG-026C-Graphic%2c-SCD-PROTECT-Time-to-Appropriate-Treatment%2c-Graph.png?width=903&height=716&name=IMG-026C-Graphic%2c-SCD-PROTECT-Time-to-Appropriate-Treatment%2c-Graph.png "IMG-026C-Graphic,-SCD-PROTECT-Time-to-Appropriate-Treatment,-Graph")

![rhythm-tracings-NoGradient\_GIF\_v8\_LD-1](https://resources.kestramedical.com/hs-fs/hubfs/2025%20HFSA/rhythm-tracings-NoGradient_GIF_v8_LD-1.gif?width=1200&height=540&name=rhythm-tracings-NoGradient_GIF_v8_LD-1.gif "rhythm-tracings-NoGradient_GIF_v8_LD-1")

### Protecting Against SCD Is Only Half the Story

Anchored by the ASSURE® WCD, the Cardiac Recovery System® (CRS) platform bridges the gap by pairing proven protection with insights to support recovery. 

The Cardiac Recovery System platform:

- Provides insights that may be helpful in care optimization, including arrhythmia detection (VT/VF, SVT and Bradyarrhythmia) and physiologic trends (heart rate and activity)
- Extends care team's reach through timely clinical alerts & rapid post-shock support

By combining proven therapy with increased visibility, the CRS platform empowers providers to protect patients and support their recovery as GDMT reaches full effect.  

![hfsa-circle\_products\_opaque-1](https://resources.kestramedical.com/hs-fs/hubfs/2025%20HFSA/hfsa-circle_products_opaque-1.png?width=1000&height=849&name=hfsa-circle_products_opaque-1.png "hfsa-circle_products_opaque-1")

Visit Booth 4617 to discover how Kestra is raising the standard for SCA risk management

1. Duncker D. et al. European Heart Journal. 2025;00:1–10.
2. Duncker, D., et al. Clin Cardiol. 2017;40(8):586-590.

## THE FUTURE OF SCA RISK MANAGEMENT STARTS HERE

 

Video player - CB-hfsa-post\_thumb-play - Click to play video

#### AHA SCIENTIFIC SESSIONS 2025

#### Late-Breaking Science Abstract Presentation

Primary Results from the Post Approval Study of a Next Generation Wearable Cardioverter Defibrillator System: the ACE-PAS Trial 

Monday, November 10, 2025 @ 8:44 AM • Session Location: 211–213

 

## The Cardiac Recovery System Platform Redefines SCA Risk Management

### Designed for Daily Life

![hfsa-circle-garment-female](https://resources.kestramedical.com/hs-fs/hubfs/2025%20HFSA/hfsa-circle-garment-female.png?width=300&height=300&name=hfsa-circle-garment-female.png)

With the most customizable fit in the category—seven sizes and two styles—the ASSURE system delivers exceptional comfort and compliance.

- Up to 87% fewer patients experiencing false alarms than competing WCD patients\*3,4

\* Disclaimer: A controlled, head-to-head study evaluating the comparative performance of these devices has not been done.

### Insights to Inform Care

![hfsa-circle\_insights](https://resources.kestramedical.com/hs-fs/hubfs/2025%20HFSA/hfsa-circle_insights.png?width=300&height=300&name=hfsa-circle_insights.png)

In real-world use, the ASSURE system identified potentially actionable cardiac events5,6:

- Detected arrhythmias in 18% of patients, leading to physician-directed clinical intervention

### An Extension of Your Care Team

![hfsa-circle\_physician](https://resources.kestramedical.com/hs-fs/hubfs/2025%20HFSA/hfsa-circle_physician.png?width=300&height=300&name=hfsa-circle_physician.png)

Connected services enable timely clinical intervention and patient support.

[Download the Cardiac Recovery System Platform Flyer](https://resources.kestramedical.com/hubfs/Brochures%20and%20Flyers/MKT-00156-01_A%2c%20Heart%20Failure%20Flyer%2c%20HFSA25.pdf?hsLang=en)

1. ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS) NCT05135403, Cohort April 2024.
2. Arkles, J. et al. J Interv Card Electrophyiol. 2023;66(7):1723-1728
3. Phukan A. et el. Clinical Impact of Ventricular and Supraventricular Arrhythmia Detection with a Novel Wearable Cardioverter Defibrillator. American Heart Association Scientific Sessions. Nov, 2024. Chicago, IL
4. Syed Z. et el. Initial Real-world Experience with a Novel Wearable Cardioverter Defibrillator. American Heart Association Scientific Sessions. Nov, 2024. Chicago, IL

## Booth Highlights

#### Step into the heart of innovation at Booth 4617 and experience the CRS platform as an immersive multimedia experience.

 

Video player - HFSA sizzle reel thumbnail - Click to play video

![IMG-00XXA-Graphic,-cup-beignet,-v3](https://resources.kestramedical.com/hubfs/IMG-00XXA-Graphic%2c-cup-beignet%2c-v3.png "IMG-00XXA-Graphic,-cup-beignet,-v3")

## Featured In-Booth Activity

### Coffee & Beignets with ACE-PAS Abstract Authors

Monday, November 10 @ 9:15 AM

Start your morning with coffee, beignets, and scientific insights. Meet the authors behind the abstract, ask questions, and enjoy a moment of connection.

## Find Us @ Booth #4617

![AHA-Floor-Map](https://resources.kestramedical.com/hs-fs/hubfs/2025%20AHA/AHA-Floor-Map.png?width=1410&height=732&name=AHA-Floor-Map.png "AHA-Floor-Map")

 

## Schedule a VIP Meeting @ AHA

### Stay Up to Date

Follow us on social:

[![social-linkedin](https://resources.kestramedical.com/hs-fs/hubfs/2025%20HFSA/social-linkedin.png?width=60&height=60&name=social-linkedin.png)](https://www.linkedin.com/company/kestra-medical-technologies-inc./)   [![social-x](https://resources.kestramedical.com/hs-fs/hubfs/2025%20HFSA/social-x.png?width=60&height=60&name=social-x.png)](https://twitter.com/kestramedical)   [![social-facebook](https://resources.kestramedical.com/hs-fs/hubfs/2025%20HFSA/social-facebook.png?width=60&height=60&name=social-facebook.png)](https://www.facebook.com/KestraMedical/)

MKT-00163-01\_B

[![Kestra\_Color White\_RGB-1199x327-c5d5cf8](https://resources.kestramedical.com/hs-fs/hubfs/Kestra_Color%20White_RGB-1199x327-c5d5cf8.png?width=150&height=41&name=Kestra_Color%20White_RGB-1199x327-c5d5cf8.png "Kestra_Color White_RGB-1199x327-c5d5cf8")](https://resources.kestramedical.com/?hsLang=en)

linkedin-in icon [facebook-f icon](https://www.facebook.com/KestraMedical/)

**ASSURE System**

[For Patients](https://www.kestramedical.com/patients)

[For Providers](https://www.kestramedical.com/providers)

**Support**

[Contact Us](https://www.kestramedical.com/contact)

[Patient FAQ](https://www.kestramedical.com/patients#faqs)

**About Kestra**

[Who We Are](https://www.kestramedical.com/about)

[Careers](https://apply.workable.com/kestra-medical-technologies-inc/)

[Press & Media](https://investors.kestramedical.com/news-events/news-releases)

[Investor Relations](https://investors.kestramedical.com)

[Privacy Policy](https://www.kestramedical.com/notice-of-privacy-practices)

[Terms of Use](https://www.kestramedical.com/terms-of-use)

[Responsible Disclosure Process](https://www.kestramedical.com/responsible-disclosure-process)

Copyright © 2026, Kestra Medical Technologies, Inc